EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?

Emmanuel Mammoliti, Suzanne Nielsen iD, Amanda Roxburgh iD

Drug and Alcohol Review · 2026-01 · 45 (1)

DOI: 10.1111/dar.14079 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Drug and Alcohol Review, online erschienen am 28.05.2025. Verfasst von Emmanuel Mammoliti und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Drug Research Institute, Curtin University, Perth, Australia. Hauptthemen laut MEDLINE: Analgesics, Opioid, Harm Reduction, Illicit Drugs, Opioid-Related Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Issues Rising synthetic opioid deaths in North America, and the emergence of nitazene harms has driven concern about novel synthetic opioids (NSO) in Australia. This scoping review aimed to map what is known about NSOs in Australia. Approach Scoping review of peer‐reviewed and grey literature on NSO detections and harms. Criteria: studies describing NSO market indicators and harms in Australia. Key Findings Overall, 912 peer‐reviewed studies were identified; 40 met criteria. Monitoring systems identified NSOs (e.g., β‐U10, nitazenes) for the first time in Australia. Nitazene toxicity appeared in emergency departments ( N = 11, 2021‐onwards), two involved intentional consumption. NSOs for sale to Australia on cryptomarkets comprised < 1% of drug listings. Mortality studies identified fentanyl analogues (furanylfentanyl, acetylfentanyl) ( N = 22, 2013–2021), and other NSO U‐47700; ( N = 12, 2016–2021) deaths. Thirty‐three nitazene deaths were reported; 24 in Victoria (2021‐onwards); 7 in SA (2022‐onwards); two in NSW (2024). Australian Federal Police reported 47 nitazene seizures since July 2023. Fifty‐one drug alerts were identified (2019–2024); 18 (34%) involved NSOs; 12 (24%) for nitazenes. Overall, 12 alerts were for NSO‐contaminated stimulants; at least two fatal overdoses were confirmed due to NSO‐contaminated stimulants.

Implications

Australia has strong monitoring capacity for NSOs post‐consumption. Harms occurring among opioid‐naïve people unknowingly purchasing NSOs suggest a role for drug checking and cautious use of nitazene testing strips. Expanding take‐home naloxone availability in entertainment settings, and to all who use drugs, is warranted.

Conclusion

This review demonstrated the recent and limited emergence of NSOs in Australia. Demand for NSOs is not yet clear; availability and harms are rapidly changing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidHarm ReductionIllicit DrugsOpioid-Related DisordersSynthetic DrugsHumansAustraliaDrug Overdose

Stichwörter der Autor:innen

fentanyl analoguesharm reductionnitazenesnovel synthetic opioidspotent synthetic opioids

Substanzen

Analgesics, OpioidIllicit DrugsSynthetic Drugs

Autor:innen und Institutionen

  • National Drug Research Institute, Curtin University, Perth, Australia.
  • Disease Elimination, Burnet Institute, Melbourne, Australia.
  • Monash Addiction Research Centre, Monash University, Melbourne, Australia.

ORCID-Profile: Suzanne Nielsen, Amanda Roxburgh

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Mammoliti, E., Nielsen, S., & Roxburgh, A. (2026). A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?. Drug and Alcohol Review, 45(1). https://doi.org/10.1111/dar.14079

Vancouver

Mammoliti E, Nielsen S, Roxburgh A. A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?. Drug and Alcohol Review. 2026;45(1). doi:10.1111/dar.14079

BibTeX
@article{Mammoliti2026,
  author = {Mammoliti, Emmanuel and Nielsen, Suzanne and Roxburgh, Amanda},
  title = {A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {1},
  doi = {10.1111/dar.14079}
}
Kostenlos starten →